# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001390478-14-000075
Filing Date
2014-11-20
Accepted
2014-11-20 16:23:36
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | a424b5-lp.htm | 424B5 | 454483
2 | GRAPHIC | modifieddocumentgalen_image1.jpg | GRAPHIC | 12851
3 | GRAPHIC | modifieddocumentgalen_image3.jpg | GRAPHIC | 177196
4 | GRAPHIC | pipeline13nov1copy.jpg | GRAPHIC | 298500
| Complete submission text file | 0001390478-14-000075.txt |  | 1129401

Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-188849 | Film No.: 141239299
SIC: 2834 Pharmaceutical Preparations